Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
Sandur Manganese completed G. P. Kundargi's second consecutive term as Independent Director on 11 November 2026. He was re-appointed as a Non-Executive Director from 12 November 2026, subject to shareholder approval.
Sandur Manganese & Iron Ores issued a postal ballot notice seeking shareholder approval to appoint G. P. Kundargi as Non-Executive Director. Remote e-voting runs from 9 November to 8 December 2026.
Q2FY27 consolidated total income ₹1,519 Cr (+22% YoY), EBITDA ₹391 Cr (+37%), PAT ₹261 Cr (+88%). Margins expanding; diversifying into medtech and steel.
Sandur Manganese appointed G. P. Kundargi as a Non-Executive Director from 12 November 2026, subject to shareholder approval. He brings mining and metals experience.
Sandur Manganese & Iron Ores Ltd reported revenue from operations of ₹1,506 Cr (+22.2% YoY) and net profit of ₹261.2 Cr (+88.0% YoY) for Q2 FY27.
Sandur Manganese & Iron Ores will hold a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the meeting.
SMIORE's subsidiary Royal Sandur MedTech leased 6.2 acres at AP MedTech Zone, Visakhapatnam for a medical devices manufacturing unit. This marks the company's entry into the medical devices segment.
Sandur Manganese & Iron Ores Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
The Sandur Manganese & Iron Ores Ltd incorporated a new wholly owned subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.
Sandur Manganese & Iron Ores approved the incorporation of a wholly-owned subsidiary, 'Royal Sandur MedTech Private Limited', with a capital investment of ₹1 Crore.
Sandur Manganese & Iron Ores Ltd's subsidiary, Royal Sandur Metals Private Limited, received a customs penalty order of ₹0.12 Crore.
The Sandur Manganese & Iron Ores Limited announced name changes for two material subsidiaries, Arjas Steel and Arjas Modern Steel, as part of a group re-branding.
The Sandur Manganese & Iron Ores Limited concluded its 72nd Annual General Meeting on 19 August 2026 via video conferencing, with all agenda items discussed.
The Sandur Manganese & Iron Ores Limited incorporated a new wholly owned subsidiary, Royal Sandur Academy Private Limited, with an investment of ₹1 Crore.